Medistim ASA
OSE:MEDI
Medistim ASA
Revenue
Medistim ASA
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medistim ASA
OSE:MEDI
|
Revenue
kr562.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Lifecare AS
OSE:LIFE
|
Revenue
kr13.1m
|
CAGR 3-Years
34%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
O
|
Observe Medical ASA
OSE:OBSRV
|
Revenue
kr27.9m
|
CAGR 3-Years
111%
|
CAGR 5-Years
203%
|
CAGR 10-Years
N/A
|
|
Medistim ASA
Glance View
Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.
See Also
What is Medistim ASA's Revenue?
Revenue
562.6m
NOK
Based on the financial report for Dec 31, 2024, Medistim ASA's Revenue amounts to 562.6m NOK.
What is Medistim ASA's Revenue growth rate?
Revenue CAGR 10Y
10%
Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for Medistim ASA have been 10% over the past three years , 9% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet